Target Price | $152.14 |
Price | $132.87 |
Potential |
14.51%
register free of charge
|
Number of Estimates | 10 |
10 Analysts have issued a price target DaVita HealthCare Partners 2026 .
The average DaVita HealthCare Partners target price is $152.14.
This is
14.51%
register free of charge
$195.30
46.99%
register free of charge
$138.37
4.14%
register free of charge
|
|
A rating was issued by 17 analysts: 1 Analysts recommend DaVita HealthCare Partners to buy, 10 to hold and 6 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the DaVita HealthCare Partners stock has an average upside potential 2026 of
14.51%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 12.82 | 13.58 |
5.56% | 5.96% | |
EBITDA Margin | 20.90% | 20.72% |
8.14% | 0.87% | |
Net Margin | 7.31% | 6.00% |
28.26% | 17.88% |
11 Analysts have issued a sales forecast DaVita HealthCare Partners 2025 . The average DaVita HealthCare Partners sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an DaVita HealthCare Partners EBITDA forecast 2025. The average DaVita HealthCare Partners EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 DaVita HealthCare Partners Analysts have issued a net profit forecast 2025. The average DaVita HealthCare Partners net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 10.73 | 10.97 |
44.61% | 2.24% | |
P/E | 12.11 | |
EV/Sales | 1.40 |
11 Analysts have issued a DaVita HealthCare Partners forecast for earnings per share. The average DaVita HealthCare Partners EPS is
This results in the following potential growth metrics and future valuations:
DaVita HealthCare Partners...
Analyst | Rating | Action | Date |
---|---|---|---|
B of A Securities |
Locked
➜
Locked
|
Locked | Sep 10 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | May 19 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Feb 18 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Oct 31 2024 |
Truist Securities |
Locked
➜
Locked
|
Locked | Oct 07 2024 |
Truist Securities |
Locked
➜
Locked
|
Locked | Aug 20 2024 |
Analyst Rating | Date |
---|---|
Locked
B of A Securities:
Locked
➜
Locked
|
Sep 10 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Aug 07 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
May 19 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Feb 18 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Oct 31 2024 |
Locked
Truist Securities:
Locked
➜
Locked
|
Oct 07 2024 |
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 20 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.